Lexeo Therapeutics (LXEO) EPS (Basic) (2022 - 2026)
Lexeo Therapeutics (LXEO) reported EPS (Basic) of -$0.25 for Q1 2026, up 74.77% on a YoY basis from -$0.14 in Q1 2025, and up 37.77% sequentially from -$0.4 in Q4 2025.
Lexeo Therapeutics (LXEO) EPS (Basic) (2022 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 5 years of EPS (Basic) data on file, last reported at -$0.25 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 74.77% year-over-year to -$0.25; the trailing twelve-month figure through Mar 2026 stood at -$1.08 (up 67.15% YoY), and the FY2025 full-year result was -$4.14, down 33.81% from the prior year.
- EPS (Basic) advanced to -$0.25 in Q1 2026, from -$0.4 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.25 in Q1 2026 to a low of -$12.36 in Q3 2023.
- A 5-year average of -$3.99 and a median of -$0.89 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) jumped 93.31% in 2024 and slipped 27.26% in 2025, its largest moves.
- Tracing LXEO's EPS (Basic) over 5 years: stood at -$8.94 in 2022, then soared by 70.37% to -$2.65 in 2023, then soared by 69.22% to -$0.82 in 2024, then soared by 50.98% to -$0.4 in 2025, then surged by 37.77% to -$0.25 in 2026.
- Business Quant data shows LXEO's EPS (Basic) at -$0.25 in Q1 2026, -$0.4 in Q4 2025, and -$0.33 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Lexeo Therapeutics | 379.94 Mn | 379.94 Mn | - | -0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.25 |
| Dec 31, 2025 | -0.40 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.60 |
| Mar 31, 2025 | -0.99 |
| Dec 31, 2024 | -0.82 |
| Sep 30, 2024 | -0.89 |
| Jun 30, 2024 | -0.64 |
| Mar 31, 2024 | -0.77 |
| Dec 31, 2023 | -2.65 |
| Sep 30, 2023 | -12.36 |
| Jun 30, 2023 | -8.30 |
| Mar 31, 2023 | -11.58 |
| Dec 31, 2022 | -8.94 |
| Sep 30, 2022 | -10.38 |